Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1982 1
1983 2
1984 1
1985 2
1986 1
1988 2
1989 3
1990 2
1991 4
1992 3
1993 1
1994 2
1995 1
1996 1
1997 4
1998 4
1999 2
2000 3
2001 3
2002 4
2003 7
2004 4
2005 9
2006 10
2007 6
2008 5
2009 4
2010 6
2011 4
2012 9
2013 8
2014 13
2015 9
2016 9
2017 9
2018 6
2019 13
2020 8
2021 15
2022 11
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and management of parathyroid carcinoma: a state-of-the-art review.
Roser P, Leca BM, Coelho C, Schulte KM, Gilbert J, Drakou EE, Kosmas C, Ling Chuah L, Wassati H, Miras AD, Crane J, Aylwin SJB, Grossman AB, Dimitriadis GK. Roser P, et al. Endocr Relat Cancer. 2023 Mar 22;30(4):e220287. doi: 10.1530/ERC-22-0287. Print 2023 Apr 1. Endocr Relat Cancer. 2023. PMID: 36621911 Review.
Parathyroid carcinoma is one of the least common endocrine malignancies and accounts for approximately 1% of all patients with primary hyperparathyroidism. ...Study quality was evaluated using the Newcastle-Ottawa Scale for observational studies. This review
Parathyroid carcinoma is one of the least common endocrine malignancies and accounts for approximately 1% of all patients with
Parathyroid carcinoma.
Salcuni AS, Cetani F, Guarnieri V, Nicastro V, Romagnoli E, de Martino D, Scillitani A, Cole DEC. Salcuni AS, et al. Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):877-889. doi: 10.1016/j.beem.2018.11.002. Epub 2018 Dec 1. Best Pract Res Clin Endocrinol Metab. 2018. PMID: 30551989 Review.
Parathyroid carcinoma (PC) is a rare disease with an indolent behavior due to the low malignant potential. ...The best chance of cure is the complete surgical resection with the en-bloc excision at the first operation, however several recurrences are often observ
Parathyroid carcinoma (PC) is a rare disease with an indolent behavior due to the low malignant potential. ...The best chance
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.
Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Solórzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE. Wilhelm SM, et al. JAMA Surg. 2016 Oct 1;151(10):959-968. doi: 10.1001/jamasurg.2016.2310. JAMA Surg. 2016. PMID: 27532368
Devascularized normal parathyroid tissue should be autotransplanted. Patients should be observed postoperatively for hematoma, evaluated for hypocalcemia and symptoms of hypocalcemia, and followed up to assess for cure defined as eucalcemia at more than 6 months. Calcium s …
Devascularized normal parathyroid tissue should be autotransplanted. Patients should be observed postoperatively for hematoma, evalua …
Association of parathyroid carcinoma and thyroid disorders: A clinical review.
Campennì A, Giovinazzo S, Pignata SA, Di Mauro F, Santoro D, Curtò L, Trimarchi F, Ruggeri RM, Baldari S. Campennì A, et al. Endocrine. 2017 Apr;56(1):19-26. doi: 10.1007/s12020-016-1147-7. Epub 2016 Oct 15. Endocrine. 2017. PMID: 27744598 Review.
The search was prompted by the observation of a never reported association of autonomously functioning thyroid nodules and parathyroid carcinoma. ...Serum parathyroid hormone and calcium levels are high in the majority of parathyroid carcinoma p …
The search was prompted by the observation of a never reported association of autonomously functioning thyroid nodules and parathy
Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma.
Jo SY, Hong N, Lee S, Jeong JJ, Won J, Park J, Kim GJ, Kim SK, Kim S, Rhee Y. Jo SY, et al. Exp Mol Med. 2023 May;55(5):886-897. doi: 10.1038/s12276-023-00968-4. Epub 2023 May 1. Exp Mol Med. 2023. PMID: 37121965 Free PMC article.
A molecular classification model based on carcinoma-specific genes clearly separated carcinomas from adenomas and normal tissues, the clinical utility of which was demonstrated in two patients with uncertain malignant potential. A deeper analysis of gene expression and functional …
A molecular classification model based on carcinoma-specific genes clearly separated carcinomas from adenomas and normal tissues, the clinic …
Parathyroid Carcinoma: Diagnosis and Clinical Implications.
Duan K, Mete Ö. Duan K, et al. Turk Patoloji Derg. 2015;31 Suppl 1:80-97. doi: 10.5146/tjpath.2015.01316. Turk Patoloji Derg. 2015. PMID: 26177319 Free article. Review.
Parathyroid carcinoma is a rare type of endocrine cancer, with significant morbidity and mortality associated with parathyroid hormone (PTH)-mediated hypercalcemia. ...This review provides an update on the current knowledge of parathyroid carcinoma and
Parathyroid carcinoma is a rare type of endocrine cancer, with significant morbidity and mortality associated with parathyroid
Update on parathyroid carcinoma.
Cetani F, Pardi E, Marcocci C. Cetani F, et al. J Endocrinol Invest. 2016 Jun;39(6):595-606. doi: 10.1007/s40618-016-0447-3. Epub 2016 Mar 21. J Endocrinol Invest. 2016. PMID: 27001435 Review.
INTRODUCTION: Parathyroid carcinoma (PC) is a rare endocrine disorder, commonly causing severe primary hyperparathyroidism (PHPT). ...The association of CDC73 mutations and loss of parafibromin predicts a worse clinical outcome and a lower overall 5- and 10-y …
INTRODUCTION: Parathyroid carcinoma (PC) is a rare endocrine disorder, commonly causing severe primary hyperparathyroidism (PH …
Surgical Aspects of Primary Hyperparathyroidism.
Perrier N, Lang BH, Farias LCB, Poch LL, Sywak M, Almquist M, Vriens MR, Yeh MW, Shariq O, Duh QY, Yeh R, Vu T, LiVolsi V, Sitges-Serra A. Perrier N, et al. J Bone Miner Res. 2022 Nov;37(11):2373-2390. doi: 10.1002/jbmr.4689. Epub 2022 Oct 17. J Bone Miner Res. 2022. PMID: 36054175 Free article. Review.
This review updates surgical aspects of PHPT and proposes the following definitions based on international expert consensus: selective PTX (and reasons for conversion to an extended procedure), bilateral neck exploration for non-localized or multigland disease, subtotal PTX, tota …
This review updates surgical aspects of PHPT and proposes the following definitions based on international expert consensus: selective PTX ( …
Parathyroid carcinoma: Single centre experience.
Cunha C, Pinheiro SL, Donato S, Tavares Bello C, Simões H, Nunes Silva T, Prazeres S, Doutel D, Cavaco BM, Leite V. Cunha C, et al. Clin Endocrinol (Oxf). 2022 Sep;97(3):250-257. doi: 10.1111/cen.14684. Epub 2022 Feb 9. Clin Endocrinol (Oxf). 2022. PMID: 35120263
OBJECTIVE: Parathyroid Carcinoma is a rare malignant neoplasm, accounting for less than 1% of primary hyperparathyroidism cases. ...Three patients underwent adjuvant radiotherapy. Recurrence was observed in 8 cases (47.1%) after a median of 24 months followin …
OBJECTIVE: Parathyroid Carcinoma is a rare malignant neoplasm, accounting for less than 1% of primary hyperparathyroidism case …
Parathyroid carcinoma: Challenges in diagnosis and treatment.
Betea D, Potorac I, Beckers A. Betea D, et al. Ann Endocrinol (Paris). 2015 May;76(2):169-77. doi: 10.1016/j.ando.2015.03.003. Epub 2015 Apr 21. Ann Endocrinol (Paris). 2015. PMID: 25910997 Review.
Parathyroid carcinoma is a malignant neoplasm affecting 0.5 to 5.0% of all patients suffering from primary hyperparathyroidism. ...The third/second generation PTH assay ratio provides valuable information to distinguish between benign parathyroid disease and para
Parathyroid carcinoma is a malignant neoplasm affecting 0.5 to 5.0% of all patients suffering from primary hyperparathyroidism
202 results